Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01681849 · ClinicalTrials.gov registry record · Phase 4
Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 91
- Enrollment target
NCT01681849 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 91 participants.
The verdict
NCT01681849, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this study was to assess the effects of the medication paroxetine on symptoms of posttraumatic stress disorder (PTSD) and the brain in women with a history of PTSD related to childhood abuse. The hypothesis is that paroxetine will result in an improvement in PTSD symptoms accompanied by changes in brain functional response to reminders of childhood trauma.
Interventions
- DRUG Placebo
- DRUG Paroxetine
- OTHER Positron Emission Tomography (PET) Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2009-07 |
| Est. Completion | 2015-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01681849
The ClinicalTrials.gov registry entry for NCT01681849 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01681849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01681849 about?
NCT01681849 is a clinical study titled "Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder". The purpose of this study was to assess the effects of the medication paroxetine on symptoms of posttraumatic stress disorder (PTSD) and the brain in women with a history of PTSD related to childhood abuse. The hypothesis is that paroxetine will result in an improvement in PTSD symptoms accompanied ...
What is the current status of trial NCT01681849?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 91 participants. The study started on 2009-07. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01681849?
The interventions under investigation include: Placebo (DRUG), Paroxetine (DRUG), Positron Emission Tomography (PET) Imaging (OTHER).
Who is sponsoring clinical trial NCT01681849?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.